ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

7-Chlorothieno[3,2-b]pyridine → tert-butyl 4-((2-(3-phenoxy-5-(thieno[3,2-b]pyridin-7-ylthio)pyridin-2-Ylamino)thiazol-4-yl)methyl)piperidine-1-carboxylate

HRID 1806189
印刷

反応式

HRID 1806189 の反応式
CC([O-])(C)C.[K+].Cl[C:8]1[CH:13]=[CH:12][N:11]=[C:10]2[CH:14]=[CH:15][S:16][C:9]=12.COC(=O)CC[S:22][C:23]1[CH:24]=[C:25]([O:49][C:50]2[CH:55]=[CH:54][CH:53]=[CH:52][CH:51]=2)[C:26]([NH:29][C:30]2[S:31][CH:32]=[C:33]([CH2:35][CH:36]3[CH2:41][CH2:40][N:39]([C:42]([O:44][C:45]([CH3:48])([CH3:47])[CH3:46])=[O:43])[CH2:38][CH2:37]3)[N:34]=2)=[N:27][CH:28]=1>CS(C)=O>[O:49]([C:25]1[C:26]([NH:29][C:30]2[S:31][CH:32]=[C:33]([CH2:35][CH:36]3[CH2:37][CH2:38][N:39]([C:42]([O:44][C:45]([CH3:48])([CH3:47])[CH3:46])=[O:43])[CH2:40][CH2:41]3)[N:34]=2)=[N:27][CH:28]=[C:23]([S:22][C:8]2[CH:13]=[CH:12][N:11]=[C:10]3[CH:14]=[CH:15][S:16][C:9]=23)[CH:24]=1)[C:50]1[CH:55]=[CH:54][CH:53]=[CH:52][CH:51]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 112752517-Chlorothieno[3,2-b]pyridineHCID 23665647Potassium tert-butoxideHCID 57742831Tert-butyl 4-((2-(5-(3-methoxy-3-oxopropylthio)-3-phenoxypyridin-2-ylamino)thiazol-4-yl)methyl)piperidine-1-carboxylate

生成物 1

HCID 57742604tert-butyl 4-((2-(3-phenoxy-5-(thieno[3,2-b]pyridin-7-ylthio)pyridin-2-Ylamino)thiazol-4-yl)methyl)piperidine-1-carboxylate収率 97.4%

試薬・触媒・溶媒 1

HCID 679Dimethyl Sulfoxide溶媒

実験手順

Added potassium 2-methylpropan-2-olate (0.443 g, 3.95 mmol) to a solution of 7-chlorothieno[3,2-b]pyridine (0.268 g, 1.58 mmol) and tert-butyl 4-((2-(5-(3-methoxy-3-oxopropylthio)-3-phenoxypyridin-2-ylamino)thiazol-4-yl)methyl)piperidine-1-carboxylate (0.77 g, 1.32 mmol) in DMSO (8 mL). The reaction was stirred for two hours, then set aside to react at ambient temperature for 60 hours. The reaction was partitioned between ethyl acetate and saturated ammonium chloride. Washed the organic layer twice with water and brine, dried, and concentrated. The residue was purified by MPLC (Biotage) eluting with 1:1 hexane:ethyl acetate. The major UV active component with an Rf of 0.3 was collected and concentrated to afford the title compound (0.810 g, 97.4% yield) as a white powder: 1H NMR (CDCl3) δ 8.88 (s, 1H), 8.46 (d, 1H), 8.32 (s, 1H), 7.72 (d, 1H), 7.54 (d, 1H), 7.38 (t, 2H), 7.20 (t, 1H), 7.18 (s, 1H), 7.04 (d, 2H), 6.73 (d, 1H), 6.51 (s, 1H), 4.09 (m, 2H), 2.68 (m, 2H), 2.59 (d, 2H), 1.87 (m, 1H), 1.66 (m, 2H), 1.45 (s, 9H), 1.16 (m, 2H).

後処理

  1. customto react at ambient temperature for 60 hours
  2. customThe reaction was partitioned between ethyl acetate and saturated ammonium chloride
  3. washWashed the organic layer twice with water and brine
  4. customdried
  5. concentrationconcentrated
  6. customThe residue was purified by MPLC (Biotage)
  7. washeluting with 1:1 hexane
  8. customThe major UV active component with an Rf of 0.3 was collected
  9. concentrationconcentrated

出典と根拠

ORDレコード
ord-da93d6a33c7946a989a15db16f76daee
出典データセット
uspto-grants-2013_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08354540B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート